FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent...

8
FSC-A FSC-A ICOS Life/ Dead SSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP reporter mice were infected intranasally with C. neoformans 1841 and analysed at indicated time points (n = 6 mice/experiment). Gating strategy for identification of IL-13-competent pulmonary cells is shown. One of two experiments is shown.

description

Figure S3 Figure S3 Comparison of cytokine production by pulmonary cells from st2 -/- and il17rb/st2 -/- mice Mice were infected intranasally with C. neoformans 1841 and analysed 21 dpi (n = 5-7 mice/experiment). ELISA of supernatants of pulmonary leukocytes restimulated with ionomycin and phorbol 12-myristate 13-acetate for 4 h. Ratios are calculated as x-fold amount of each cytokine produced by individual st2 -/- or il17rb/st2 -/- mouse compared to corresponding wt control mice used in the same experiment as experiments with st2 -/- and il17rb/st2 -/- mice were independently performed. Two-tailed unpaired t-test was performed with * = P ≤ 0.05 for IFN-γ. Mean with range is shown for IFN-γ and median with range for IL-13, IL-5, and IL-17A. One of two experiments is shown for each ratio.

Transcript of FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent...

Page 1: FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP.

FSC-A FSC-A ICOS

Life

/Dea

d

SSC-

A

IL-1

3 eG

FP

21 dpi

Figure S1

Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13eGFP/+ miceIL-13eGFP reporter mice were infected intranasally with C. neoformans 1841 and analysed at indicated time points (n = 6 mice/experiment). Gating strategy for identification of IL-13-competent pulmonary cells is shown. One of two experiments is shown.

Page 2: FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP.

il17rb/st2-

/-

naïve 21dpi

wt

IL-33R

GATA

3

Figure S2

Figure S2 Gating scheme for ILC2 from wt and il17rb/st2-/- mice based on GATA3 and IL-33R Wt and il17rb/st2-/- mice were infected intranasally with C. neoformans 1841 and analysed at indicated time points (n = 7 mice/experiment). Gating of Lineage negative pulmonary cells and subsequent GATA3 analysis, i.e. ILC2, is shown. One of two experiments is shown.

Page 3: FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP.

Figure S3

Figure S3 Comparison of cytokine production by pulmonary cells from st2-/- and il17rb/st2-/- miceMice were infected intranasally with C. neoformans 1841 and analysed 21 dpi (n = 5-7 mice/experiment). ELISA of supernatants of pulmonary leukocytes restimulated with ionomycin and phorbol 12-myristate 13-acetate for 4 h. Ratios are calculated as x-fold amount of each cytokine produced by individual st2-/- or il17rb/st2-/- mouse compared to corresponding wt control mice used in the same experiment as experiments with st2-/- and il17rb/st2-/- mice were independently performed. Two-tailed unpaired t-test was performed with * = P ≤ 0.05 for IFN-γ. Mean with range is shown for IFN-γ and median with range for IL-13, IL-5, and IL-17A. One of two experiments is shown for each ratio.

IL-5

0.0

0.5

1.0

1.5

2.0

x-fo

ld (o

f wt c

ontro

l)IL-17A

0

5

10

15x-

fold

(of w

t con

trol

)IFN-

0.0

0.5

1.0

1.5

2.0 *

x-fo

ld (o

f wt c

ontr

ol)

IL-13

0.0

0.5

1.0

1.5

2.0st2-/-il17rb/st2-/-

x-fo

ld (o

f wt c

ontr

ol)

Page 4: FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP.

Figure S4

Figure S4 Pulmonary PAS-score and gob5 expression in il17rb/st2-/- miceil17rb/st2-/- mice were infected intranasally with C. neoformans 1841 and analysed at indicated time points (n = 7 mice/experiment). PAS score was calculated from counting PAS+ epithelial cells of ten bronchi of each mouse and gob5 expression was analysed by qPCR (as described in materials and methods section). One of two experiments is shown.

7 14 21

0.00.1

12345 il17rb/st2-/-

dpi

% P

AS+

cells

of b

ronc

hial

epi

thel

ium

gob5

naïve 7 14 21

0

10

20

30il17rb/st2-/-

dpi

x-fo

ldhp

rt

Page 5: FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP.

wt 21dpi

wt naïve

il17rb/st2-/-

21dpi

Foxp3

IL-3

3R

Gated on living CD4+ T singlet cells

Figure S5

GATA3

wt 21dpi

Figure S5 Th cells subsets from wt mice show IL-33R-dependent GATA3 expressionWt and il17rb/st2-/- mice were infected intranasally with C. neoformans 1841 and analysed at indicated time points (n = 7 mice/experiment). Gating strategy for analysis of GATA3 in pulmonary Th cell subsets based on IL-33R and Foxp3 expression is shown. GATA3 MFI (APC) is shown for 21dpi wt mouse.

Page 6: FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP.

102

103

104

naïve 21dpi

*** ******wtil17rb/st2-/-

Ym1

grey

val

ue (m

ean)

il17rb/st2-/- wt21 dpinaïve

il17rb/st2-/- wt

Ym1

Hoec

hst

Figure S6

Figure S6 Ym1 immunofluorescence with sorted alveolar macrophages from wt and il17rb/st2-/- miceYm1 (protein product of chi3l3) staining intensity expressed as grey values (see materials and methods section) is shown for alveolar macrophages from naïve and 21 dpi mice (il17rb/st2-/- mice white boxes, wt mice grey boxes) with representative staining for Ym1 (top row) and corresponding nucleus stain with Hoechst 33342 (bottom row). Kruskal-Wallis test with Dunn's Multiple Comparison Test was performed with *** = P ≤ 0.001. One of two experiments is shown.

Page 7: FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP.

naïve 14 dpi0.0

0.5

1.0

1.5rag2-/-rag2/c-/-

notdetected

notdetected

notdetected

notdetected

IL-1

3 [n

g/m

L]

naïve 14 dpi0.0

0.5

1.0

1.5rag2-/-rag2/c-/-

notdetected

notdetected

IL-5

[ng/

mL]

Figure S7

Figure S7 Supernatant analysis of pulmonary cells from rag2-/- and rag2/γc-/- mice

Page 8: FSC-A ICOS Life/DeadSSC-A IL-13 eGFP 21 dpi Figure S1 Figure S1 Identification of IL-13-competent cells in lungs of infected IL-13 eGFP/+ mice IL-13eGFP.

il2 (Th cells)

naïve 21dpi0.0

0.1

0.2

0.3

0.4

0.5

wtil17rb/st2-/-

x-fo

ldhp

rt

Figure S8

Figure S8 Quantitative real time PCR analysis of sorted Th cells from wt and il17rb/st2-/- mice